LLY vs BRK.A
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
LLY · Eli Lilly and Co$1,354.00 ▼ 0.79%
BRK.A · Berkshire Hathaway-A$856,612.00 ▼ 0.01%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- LLY +41.0%
- BRK.A +15.1%
Head to head
| Metric | LLY | BRK.A |
|---|---|---|
| Price | $1,354.00 | $856,612.00 |
| Change today | ▼ 0.79% | ▼ 0.01% |
| Market cap | $1.27T | $1.22T |
| Return, 3 months | +10.1% | +7.9% |
| Return, year to date | +26.6% | +13.5% |
| Return, 1 year | +47.4% | +14.5% |
| P/E (TTM) | 43.9 | 14.4 |
| P/B | 31.6 | 1.6 |
| P/E percentile vs own 5y | 27th | 64th |
| Dividend yield | 0.49% | – |
| Revenue growth (YoY, latest qtr) | +38.6% | +19.2% |
| Net profit growth (YoY) | +15.5% | +106.9% |
| Gross margin | 83.6% | – |
| Operating margin | 51.3% | – |
| Net margin | 31.9% | 19.6% |
| Return on equity | 86.1% | 12.1% |
| Analyst target vs. price | +11.6% | -2.1% |
| Analyst buy share | 92% | 50% |
| RSI (14) | 61 | 73 |
| 30-day volatility | 34.3% | 16.5% |
| Max drawdown, 1 year | -23.2% | -9.1% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- LLY is the largest of the group by market value.
- LLY has returned the most over the past year.
- BRK.A carries the lowest trailing P/E.
- LLY is growing revenue fastest.
- LLY keeps the most profit per dollar of sales.
- BRK.A has been the calmest stock over the last 30 days.